Aggressive Serum Urate Lowering Meets Goals in Gout
At the 2022 American College of Rheumatology, ACR Convergence meeting, Dr. Sarah Black, a...
Read More
Dissemination (Meeting Coverage)
Gout Has Causal Role in the Onset of Hypertension
Past observational studies have shown a link between hypertension and gout, but whether a causal relationship existed was unclear, according to Chang-Fu Kuo, MD, PhD. For a study published in Arthritis Research & Therapy,...
Read More
Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Secondary Hematological Malignancies
Patients with aggressive hematological malignancies and second primary malignancies can develop in...
Read More
Initial Treatment for CLL/ SLL: Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab
For a study, researchers sought to determine if ibrutinib combined with fludarabine,...
Read More
Ibrutinib Treatment for CLL/SLL: Overall and Subgroup Results from the Third Interim Analysis of FIRE
FIRE is a noninterventional, multicenter observational trial of patients in France receiving...
Read More
CLL/SLL Patients: Real-World Outcomes with First-Line Ibrutinib (Ibr) VS. Chemoimmunotherapy (CIT)
With the development of cutting-edge drugs like Ibr, the treatment landscape for CLL/SLL has...
Read More
African American Patients with Diffuse Large B-Cell Lymphoma: Predictors of Inferior Survival
African American (AA) patients with diffuse large b-cell lymphoma (DLBCL) experience differences...
Read More
Neutrophil-to-Lymphocyte Ratio in Gout Suggests Sustained Post-Flare Inflammation
At the 2022 American College of Rheumatology Convergence meeting, Michael Pillinger, MD, presented...
Read More
Patients With IBS With Diarrhea Experience Significant Burden on HRQOL
For patients with irritable bowel syndrome with diarrhea (IBS-D), symptoms such as abdominal pain...
Read MoreDiffuse Large B-Cell Lymphoma Patients: Impact of Circulating Lymphoma at Diagnosis on Outcomes
The most prevalent B-cell non-Hodgkin lymphoma is diffuse large B-cell lymphoma (DLBCL). Various prognostic factors were known, including the revised international prognostic index (R-IPI), MYC/BCL2 overexpression by IHC,...
Read MorePatients With IBS With Diarrhea Experience Significant Burden on HRQOL
Patients with IBS-D had significantly higher percentages of moderate to severe anxiety and depression and considerably lower HRQOL versus controls. For patients with irritable bowel syndrome with diarrhea (IBS-D), symptoms such...
Read More
Predictor of Response to Loncastuximab Tesirine: Expression by IHC
A number of CD19-targeted medicines, such as chimeric antigen receptor T-cell therapy (CAR-T),...
Read More
Relapsed/Refractory DLBCL Patients Treated with Loncastuximab Tesirine: Predicting Outcome by Metabolic Tumor Volume
For tailored therapy selection and result optimization in diffuse large B-cell lymphoma (DLBCL),...
Read More
MIRROR RCT Trial: Addressing Gout Following Kidney Transplant
Results from the MIRROR RCT trial, presented at the 2022 American Society of Nephrology’s Kidney...
Read More
Patients With Comorbid Gout Hospitalized With COVID-19 Have Greater LOS
Gout flares occurred in 18% of patients with comorbid gout who were hospitalized for COVID-19,...
Read More
IgG-Based Diets Can Provide Relief for Some Patients With IBS
IgG-based elimination diets using a novel diagnostic tool to guide therapy may be beneficial to...
Read More
ULT for Gout Leads to Long-Term Reduction in Hospitalization Risk After Initial Spike
For patients with gout, urate-lowering therapy (ULT) increases the risk of hospitalizations within...
Read More
Baseline Cholesterol Biomarkers Impact CV Risk in Elderly Patients
Individuals with hypercholesterolemia who had higher levels of campesterol experienced...
Read More
Returning Secondary Findings Related to Hypercholesterolemia Has Clinical Benefits
Limited research has been done on outcomes after the return of secondary findings in large-scale...
Read More
PCSK9 Monoclonal Antibody Provides ‘Significant and Durable’ Decrease in LDL-C
Tafolecimab provided significant, durable decreases in low-density lipoprotein cholesterol (LDL-C)...
Read More